Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society - 1 Feb 2018

Tropea Thomas F, Xie Sharon X, Rick Jacqueline, Chahine Lana M, Dahodwala Nabila, Doshi Jimit, Davatzikos Christos, Shaw Leslie M, Van Deerlin Vivianna, Trojanowski John Q, Weintraub Daniel, Chen-Plotkin Alice S

Abstract excerpt

BACKGROUND: People with PD are at high risk of developing cognitive impairment and dementia. Cross-sectional studies have identified candidate biomarkers associated with cognitive decline. However, longitudinal studies on this topic are rarer, and few have investigated the use of biomarker panels encompassing multiple modalities. The objective of this study was to find baseline predictors of cognitive decline in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein E4
Share to Cognitive Dysfunction

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cohort Studies

Share to Cross-Sectional Studies

Share to Neuropsychological Tests

Share to Parkinson Disease

Share to Severity of Illness Index

Share to Statistics, Nonparametric

Source

Open in PubMed Open full text

Identifiers

PMID: 29168904
DOI: 10.1002/mds.27204
PMCID: PMC5809205

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease.PMID 29168904Read ↗

Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease.Semantic proximity Read ↗

An Alzheimer's Disease-Derived Biomarker Signature Identifies Parkinson's Disease Patients with Dementia.Semantic proximity Read ↗

Pre-Diagnostic Cognitive and Functional Impairment in Multiple Sporadic Neurodegenerative DiseasesSemantic proximity Read ↗

What can biomarkers tell us about cognition in Parkinson's disease?Semantic proximity Read ↗

Prediction, prognosis and monitoring of neurodegeneration at biobank-scale via machine learning and imagingSemantic proximity Read ↗

Cognitive impairment in Parkinson's disease : impact and identification of comorbid disease mechanismsSemantic proximity Read ↗

Precision Medicine: Clarity for the Complexity of Dementia.Semantic proximity Read ↗

Diagnostic biomarkers for Parkinson's disease at a glance: where are we?Semantic proximity Read ↗

Machine learning-based prediction of cognitive outcomes in de novo Parkinson’s diseaseSemantic proximity Read ↗

Motor progression phenotypes in early-stage Parkinson's Disease: A clinical prediction model and the role of glymphatic system imaging biomarkers.Semantic proximity Read ↗

Cognitive impairment in Parkinson's disease.Semantic proximity Read ↗

APOE, MAPT, and COMT and Parkinson's Disease Susceptibility and Cognitive Symptom Progression.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.